AAAAAA

   
Results: 1-14 |
Results: 14
VACCINE PROTECTION AGAINST A HETEROLOGOUS, NON-SYNCYTIUM-INDUCING, PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS
Authors: ROBERTGUROFF M KAUR H PATTERSON LJ LENO M CONLEY AJ MCKENNA PM MARKHAM PD RICHARDSON E ALDRICH K ARORA K MURTY L CARTER L ZOLLAPAZNER S SINANGIL F
Citation: M. Robertguroff et al., VACCINE PROTECTION AGAINST A HETEROLOGOUS, NON-SYNCYTIUM-INDUCING, PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS, Journal of virology (Print), 72(12), 1998, pp. 10275-10280
LONG-TERM PROTECTION OF CHIMPANZEES AGAINST HIGH-DOSE HIV-1 CHALLENGEINDUCED BY IMMUNIZATION
Authors: LUBECK MD NATUK R MYAGKIKH M KALYAN N ALDRICH K SINANGIL F ALIPANAH S MURTHY SCS CHANDA PK NIGIDA SM MARKHAM PD ZOLLAPAZNER S STEIMER K WADE M REITZ MS ARTHUR LO MIZUTANI S DAVIS A HUNG PP GALLO RC EICHBERG J ROBERTGUROFF M
Citation: Md. Lubeck et al., LONG-TERM PROTECTION OF CHIMPANZEES AGAINST HIGH-DOSE HIV-1 CHALLENGEINDUCED BY IMMUNIZATION, Nature medicine, 3(6), 1997, pp. 651-658
BIOMONITORING HUMAN EXPOSURE TO ENVIRONMENTAL CARCINOGENIC CHEMICALS
Authors: FARMER PB SEPAI O LAWRENCE R AUTRUP H NIELSEN PS VESTERGARD AB WATERS R LEURATTI C JONES NJ STONE J BAAN RA VANDELFT JHM STEENWINKEL MJST KYRTOPOULOS SA SOULIOTIS VL THEODORAKOPOULOS N BACALIS NC NATARAJAN AT TATES AD HAUGEN A ANDREASSEN A OVREBO S SHUKER DEG AMANING KS SCHOUFT A ELLUL A GARNER RC DINGLEY KH ABBONDANDOLO A MERLO F COLE J ALDRICH K BEARE D CAPULAS E ROWLEY G WAUGH APW POVEY AC HAQUE K KIRSCHVOLDERS M VANHUMMELEN P CASTELAIN P
Citation: Pb. Farmer et al., BIOMONITORING HUMAN EXPOSURE TO ENVIRONMENTAL CARCINOGENIC CHEMICALS, Mutagenesis, 11(4), 1996, pp. 363-381
RESISTANCE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TO NEUTRALIZATION BY NATURAL ANTISERA OCCURS THROUGH SINGLE AMINO-ACID SUBSTITUTIONS THATCAUSE CHANGES IN ANTIBODY-BINDING AT MULTIPLE SITES
Authors: WATKINS BA BUGE S ALDRICH K DAVIS AE ROBINSON J REITZ MS ROBERTGUROFF M
Citation: Ba. Watkins et al., RESISTANCE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TO NEUTRALIZATION BY NATURAL ANTISERA OCCURS THROUGH SINGLE AMINO-ACID SUBSTITUTIONS THATCAUSE CHANGES IN ANTIBODY-BINDING AT MULTIPLE SITES, Journal of virology, 70(12), 1996, pp. 8431-8437
HIV-1 RECOMBINANT POXVIRUS VACCINE INDUCES CROSS-PROTECTION AGAINST HIV-2 CHALLENGE IN RHESUS MACAQUES
Authors: ABIMIKU AG FRANCHINI G TARTAGLIA J ALDRICH K MYAGKIKH M MARKHAM PD CHONG PL KLEIN M KIENY MP PAOLETTI E GALLO RC ROBERTGUROFF M
Citation: Ag. Abimiku et al., HIV-1 RECOMBINANT POXVIRUS VACCINE INDUCES CROSS-PROTECTION AGAINST HIV-2 CHALLENGE IN RHESUS MACAQUES, Nature medicine, 1(4), 1995, pp. 321-329
HIGHLY ATTENUATED HIV TYPE-2 RECOMBINANT POXVIRUSES, BUT NOT HIV-2 RECOMBINANT SALMONELLA VACCINES, INDUCE LONG-LASTING PROTECTION IN RHESUS MACAQUES
Authors: FRANCHINI G ROBERTGUROFF M TARTAGLIA J AGGARWAL A ABIMIKU A BENSON J MARKHAM P LIMBACH K HURTEAU G FULLEN J ALDRICH K MILLER N SADOFF J PAOLETTI E GALLO RC
Citation: G. Franchini et al., HIGHLY ATTENUATED HIV TYPE-2 RECOMBINANT POXVIRUSES, BUT NOT HIV-2 RECOMBINANT SALMONELLA VACCINES, INDUCE LONG-LASTING PROTECTION IN RHESUS MACAQUES, AIDS research and human retroviruses, 11(8), 1995, pp. 909-920
HUMORAL AND CELLULAR IMMUNE-RESPONSES IN RHESUS MACAQUES INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2
Authors: ABIMIKU AG FRANCHINI G ALDRICH K MYAGKIKH M MARKHAM P GARD E GALLO RC ROBERTGUROFF M
Citation: Ag. Abimiku et al., HUMORAL AND CELLULAR IMMUNE-RESPONSES IN RHESUS MACAQUES INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2, AIDS research and human retroviruses, 11(3), 1995, pp. 383-393
A CONFORMATIONAL EPITOPE FROM THE C4 DOMAIN OF HIV GP120 THAT BINDS TO CD4
Authors: HARRISKELSON T ROBERTGUROFF M ROLLER P ALDRICH K BATINIC D ROBEY FA
Citation: T. Harriskelson et al., A CONFORMATIONAL EPITOPE FROM THE C4 DOMAIN OF HIV GP120 THAT BINDS TO CD4, AIDS research and human retroviruses, 11, 1995, pp. 82-82
ADENOVIRUS-HIV-1(MN) ENV RECOMBINANTS AND A SF2 GP120 BOOST PROTECT CHIMPANZEES FROM A SF2 CHALLENGE
Authors: ROBERTGUROFF M NATUK RJ MYAGKIKH M ALDRICH K ALIPANAH S KALYAN N MURTHY SCS WADE MS SINANGIL F STEIMER K NIGIDA SM ARTHUR LO MARKHAM PD GALLO RC EICHBERG JW LUBECK MD
Citation: M. Robertguroff et al., ADENOVIRUS-HIV-1(MN) ENV RECOMBINANTS AND A SF2 GP120 BOOST PROTECT CHIMPANZEES FROM A SF2 CHALLENGE, AIDS research and human retroviruses, 11, 1995, pp. 136-136
IMMUNOLOGICAL AND BIOLOGIC CONSEQUENCES OF HIV VARIABILITY
Authors: ROBERTGUROFF M WATKINS B STERN TL ALDRICH K KLASSE PJ MCKEATING J REITZ MS GALLO RC
Citation: M. Robertguroff et al., IMMUNOLOGICAL AND BIOLOGIC CONSEQUENCES OF HIV VARIABILITY, AIDS research and human retroviruses, 10, 1994, pp. 190000039-190000039
IMMUNE-RESPONSES IN RHESUS MACAQUES PROTECTED AGAINST AN HIV-2 CHALLENGE FOLLOWING VACCINATION WITH ATTENUATED POXVIRUSES CARRYING HIV-1 GENES
Authors: ABIMIKU A FRANCHINI G TARTAGLIA J ALDRICH K MYAGKIKH M MARKHAM P CHONG P KLEIN M KIENY MP PAOLETTI E GALLO R ROBERTGUROFF M
Citation: A. Abimiku et al., IMMUNE-RESPONSES IN RHESUS MACAQUES PROTECTED AGAINST AN HIV-2 CHALLENGE FOLLOWING VACCINATION WITH ATTENUATED POXVIRUSES CARRYING HIV-1 GENES, AIDS research and human retroviruses, 10, 1994, pp. 190000045-190000045
THE HIV-1 V3 LOOP CONFORMATION AND ITS GP120 CONTEXT ARE BOTH IMPORTANT FOR NEUTRALIZATION
Authors: ROBERTGUROFF M MULDOON R STERN T ALDRICH K LOUIE A GROGG D WHITESCHARF M POTTS B GALLO RC REITZ MS
Citation: M. Robertguroff et al., THE HIV-1 V3 LOOP CONFORMATION AND ITS GP120 CONTEXT ARE BOTH IMPORTANT FOR NEUTRALIZATION, Journal of acquired immune deficiency syndromes, 6(6), 1993, pp. 679-679
HIV-1, NOT HIV-2, IS PREVALENT IN NIGERIA
Authors: ABIMIKU AG ZWANDOR A KYARI S ALDRICH K KIGBU E GOMWALK N WILLIAMS E IDOKO J ANTEYI J ADENIYIJONES S ROBERTGUROFF M GALLO RC
Citation: Ag. Abimiku et al., HIV-1, NOT HIV-2, IS PREVALENT IN NIGERIA, Journal of acquired immune deficiency syndromes, 6(6), 1993, pp. 747-747
IMMUNE ESCAPE BY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 FROM NEUTRALIZING ANTIBODIES - EVIDENCE FOR MULTIPLE PATHWAYS
Authors: WATKINS BA REITZ MS WILSON CA ALDRICH K DAVIS AE ROBERTGUROFF M
Citation: Ba. Watkins et al., IMMUNE ESCAPE BY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 FROM NEUTRALIZING ANTIBODIES - EVIDENCE FOR MULTIPLE PATHWAYS, Journal of virology, 67(12), 1993, pp. 7493-7500
Risultati: 1-14 |